BRIDGEWAY CAPITAL MANAGEMENT, LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2016$66,000
-64.9%
94,4010.0%0.00%
-66.7%
Q2 2016$188,000
-17.5%
94,4010.0%0.00%
-25.0%
Q1 2016$228,000
-68.5%
94,4010.0%0.00%
-69.2%
Q4 2015$724,000
+45.1%
94,4010.0%0.01%
+30.0%
Q3 2015$499,000
-13.7%
94,401
+46.6%
0.01%
-9.1%
Q2 2015$578,00064,4010.01%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2016
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders